Champions Oncology announces board changes
This article was originally published in Scrip
Executive Summary
Champions Oncology, which develops technology solutions for personalized use of oncology medicines, has appointed Dan Mendelson and Arthur Epker to its board of directors. Mr Mendelson currently serves as chief executive officer and founder of strategic advisory firm, Avalere Health and an adjunct professor of business administration at the Fuqua School of Business, Duke University. He also sits on the boards of Coventry Health Care and HMS Holdings. Presently, Mr Epker serves as vice-president and partner of PAR Capital Management. He is a current director of Pure Cycle Corporation, the Steppingstone Foundation and the Winsor School. In conjunction with these appointments, Ana Stancic has resigned from the Champions board of directors. Furthermore, Scott Tobin, a current director of the company, has assumed the role of chair of the audit committee.
You may also be interested in...
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
In Vivo’s 2024 Rising Leaders
The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.